Lataa...
The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases
Osteocytes are the most abundant (~95%) cells in bone with the longest half-life (~25 years) in humans. In the past osteocytes have been regarded as vestigial cells in bone, since they are buried inside the tough bone matrix. However, during the last 30 years it has become clear that osteocytes are...
Tallennettuna:
| Julkaisussa: | Front Endocrinol (Lausanne) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7360678/ https://ncbi.nlm.nih.gov/pubmed/32733380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00405 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|